Home

Pre-registration is open for the 2026 AIPLA Spring Meeting in San Francisco. The Spring Meeting offers practical programming, engaging discussions, and real opportunities to build your IP network—inside and outside the meeting room.

2 members

Contact info

Link

aipla.org

Members

Raul Barrios-Genie

•

3rd+

Associate at Greenberg Traurig, LLP

Matt Hervey

•

3rd+

I am a leading expert on the legal and regulatory issues for AI, SEP-FRAND disputes, patent litigation and trade secrets. I am included in Chambers & Partners as a Global Market Leader for AI, in IAM Strategy 300 (the World's Leading IP Strategists), IAM Strategy 300 Global Leaders and in IAM 1000 as "a recognised authority on AI and all SEP/FRAND issues" and for trade secrets. Legal 500 has described me as "stand out" and "absolutely superb" for patent disputes. I am recognised by JUVE Patent as a "leading individual" for patent litigation. I am General Editor of The Law of Artificial Intelligence (Sweet & Maxwell), the leading UK practitioner's book on AI and the law. I have been described as "one of the leading global experts in AI and IP" by the UN's World Intellectual Property Organisation and was made a Fellow of the Royal Society of Arts in 2022 for leadership in the field of AI. I am a recognized authority on Generative AI, and have advised governments, inter-governmental entities and house-hold name clients across all sectors, including automotive, life sciences, finance, energy, media, fashion and retail. This includes policies, procurement, training and fine-tuning AI models, vetting datasets, leveraging international divergences in the law and technical, practical, ethical and legal mitigations against the risks of unlawful and inappropriate outputs. My guidelines on Generative AI for WIPO have been downloaded over 23,000 times. I have almost two decades of experience of SEP-FRAND litigation, including one of the largest disputes before the Patents Court of England and Wales (InterDigital v Lenovo; MIP Impact Case of the Year 2022). My SEP-FRAND cases have involved wireless and wired telecommunications standards (DECT, GSM, GPRS, EDGE, UTMS, CDMA2000, HSPA, HSPA+, LTE, LTE-Advanced, NR, G.lite, ADSL, ADSL2, ADSL2+, VDSL, VDSL2 and G.fast) and video CODEC standards (MPEG-2, MPEG-4, AVC, HEVC and VVC). My Life Sciences disputes have included monoclonal antibodies, biosimilars, toxins, medical devices and cosmetics. I successfully defended the Kennedy Trust for Rheumatology Research in the UK's first patent case on biosimilars and I helped win Fujifilm Kyowa Kirin Biologics Co., Ltd the first UK "Arrow" declaration. Other cases have involved aircraft design, software (algorithmic trading, consumer share trading platforms, 3D modelling), consumer electronics (inkjet printers), location sensing and traffic analysis.